000 01207 a2200337 4500
005 20250511231920.0
264 0 _c19910129
008 199101s 0 0 eng d
022 _a0300-8843
024 7 _a10.1111/j.1651-2227.1990.tb11702.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDanielson, K
245 0 0 _aGenotropin 16 IU KabiVial is more convenient than conventional administration systems for children on growth hormone therapy.
_h[electronic resource]
260 _bActa paediatrica Scandinavica. Supplement
_c1990
300 _a208-11 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aGrowth Disorders
_xdrug therapy
650 0 4 _aGrowth Hormone
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
_xinstrumentation
650 0 4 _aMale
650 0 4 _aPatient Compliance
650 0 4 _aRecombinant Proteins
700 1 _aNeumeyer, L
700 1 _aRitzén, M
773 0 _tActa paediatrica Scandinavica. Supplement
_gvol. 370
_gp. 208-11
856 4 0 _uhttps://doi.org/10.1111/j.1651-2227.1990.tb11702.x
_zAvailable from publisher's website
999 _c2266539
_d2266539